Karamedica, Inc, based in Raleigh, NC, is dedicated to expanding the medical and veterinary applications of biopolymer-based products, with a focus on chitosan. Their innovative non-thermal plasma technology allows for the decontamination of delicate biomaterials like chitosan, overcoming previous barriers to its clinical use.
Specializing in developing chitosan for clinical use as an implantable hemostatic device and drug delivery vehicle, Karamedica aims to address medical challenges such as controlling bleeding during surgery and treating cerebral amyloid angiopathy, a co-morbidity of Alzheimer's disease.
Generated from the website